Show simple item record

dc.contributor.authorChurchill, Jamesen
dc.contributor.authorSachdeva, Ashwinen
dc.contributor.authorJones, C.en
dc.contributor.authorIssa, Allaudinen
dc.contributor.authorFankhauser, C.en
dc.contributor.authorHudson, Andrew Men
dc.contributor.authorTran, Anna Ten
dc.contributor.authorOliveira, Pedroen
dc.contributor.authorJohnson, Hen
dc.contributor.authorLau, Maurice Wen
dc.contributor.authorParnham, Arie Sen
dc.contributor.authorSangar, Vijay Ken
dc.date.accessioned2023-07-05T09:11:06Z
dc.date.available2023-07-05T09:11:06Z
dc.date.issued2023en
dc.identifier.citationChurchill J, Sachdeva A, Jones C, Issa A, Fankhauser C, Hudson A, et al. P16 status is an independent predictor of overall survival in metastatic penile cancer in a large contemporary cohort. European Urology. 2023 Feb;83:S899-S900. PubMed PMID: WOS:000991496000622.en
dc.identifier.urihttp://hdl.handle.net/10541/626393
dc.language.isoenen
dc.titleP16 status is an independent predictor of overall survival in metastatic penile cancer in a large contemporary cohorten
dc.typeMeetings and Proceedingsen
dc.contributor.departmentThe Christie NHS Foundation Trust, Dept. of Surgery, Manchesteren
dc.identifier.journalEuropean Urologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record